LQMT has found support levels at 7.6 cents and 8 cents. In the past month the chart has made two higher highs and climbed back over the 50-day simple moving average, putting it on technical watch to potentially test the highs at 11.4 cents again. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:
UQM Technologies announced that the company will be providing the systems that Audi will be testing in its A1 e-tron extended range electric vehicles. UQM's PowerPhase systems will be used in testing that will occur through 2013 in Germany's National Platform of Electrification; the NPE is promoting this program to demonstrate and further develop the viability of electric vehicles. Longmont, CO-based UQM is focused on developing and manufacturing power-dense, high-efficiency electric motors, generators and power electronic controllers for the automotive, commercial truck, bus, marine, and military markets. In addition, UQM is developing propulsion systems for electric, hybrid electric, plug-in hybrid…
OxySure® Systems, a medical device innovator of emergency oxygen solutions, has named Jeremy M. ("Jerry") Jones, former chairman and CEO of Apria Healthcare, as an independent director effective April 1, 2013. During his more than 35 years of experience in the healthcare industry, Jones has led healthcare industry coalition efforts; served two terms as chairman of the Health Industry Distributors Association (HIDA); was a board member of the National Association of Medical Equipment Services; and was founding chairman of the Home Oxygen Services Coalition. He received the Dr. Jonas Salk Memorial Mentor in Medicine Award from the March of Dimes,…
International Stem Cell Corp., a biotechnology company focused on therapeutic and biomedical products using human parthenogenetic stem cells (hpSCs), announced its financial results for the three and twelve months ended December 31, 2012. FY 2012 Highlights: • Made significant progress in Parkinson's program including the development of a new highly-efficient manufacturing method for generating neuronal cells and conducted preliminary toxicology and pharmacology studies in animals. • Added world-recognized neurobiologist, Dr. Evan Y. Snyder, head of the FDA's Cellular, Tissue and Gene Therapies Advisory Committee, Director of the Stem Cells and Regenerative Biology Program at Sanford Burnham Medical Research Institute, as…
Leading local online media company, Local Corp. announced that it has launched “Fusion by Local,” a new premium ad network for advertisers and brand marketers. Fusion by Local helps advertisers reach targeted customers in local markets through premium display advertising inventory across some of the top media properties in the country, including in the company’s established network of over 1,000 regional media sites. Local Corporation’s new platform has launched at a promising time¬. With local display advertising on the rise and expected to grow 18.2 percent this year, advertisers are seeking ways to more effectively engage target audiences on a…
When the motion picture industry was still young, revenue was based upon one source, the money paid by the movie goer to see a movie. As the industry developed, however, companies like Disney began to realize the income potential from character development and corresponding licensing. Disney currently pulls in close to $30 billion in licensed merchandise fees, far more than it does from movie sales or other sources, and is considered the world’s top licensor. Today, the same type of ancillary monetization is being applied in the video gaming industry, though in somewhat different ways. Soul and Vibe Interactive, a…
Americas Diamond Corp. reported starting up essential site prep work today at their Natal I and II concessions, well ahead of the final bulk sampling program aimed at running some 100k tonnes of good material through the diamond recovery plant. Looking at the extant sampling and recovery rates from the project thus far, ADMC is calculating double or even quadruple (10k to 20k carats total) the generally accepted as required return needed to successfully characterize the material's diamond population. With moisture receding from what was described by the company as a very heavy rain season (over 300 inches in just…
The Securities and Exchange Commission (SEC) is mulling a pilot program to test determine whether larger trading increments would trigger more active trading in the small-cap market and result in subsidized analyst research on small stocks. The theory is that wider tick sizes would expand the spread between bid and offer prices and drive higher profits for market makers who, ideally, would subsidize research and draft revived interest in small stocks. Supporters of the program say wider minimum tick sizes will spur an increase in the number of small companies going public, while cynics contend the program will cause people…
International Stem Cell Corp., a biotechnology company specializing in the therapeutic applications of human parthenogenetic stem cells (hpSCs), today announced that it will be hosting a conference call this week to discuss its 2012 financial results as well as provide a business update. Dr. Simon Craw, Executive Vice President, and Ms. Linh Nguyen, Chief Financial Officer of International Stem Cell, will host the conference call. Those who wish to participate should use the dial-in information below. Date: Thursday March 28, 2013 Time: 11:00 a.m. ET Conference Line (U.S.): 1-877-941-2068 International Dial-In: 1-480-629-9712 Conference ID: 4610666 Webcast: http://public.viavid.com/player/index.php?id=104040 ISCO recommends logging…
Rainbow Coral this morning told investors that it is already searching for new targets that would benefit from adding licenses for the drug delivery protocols TheraKine and RBCC plan to roll out. TheraKline, developer of a revolutionary drug delivery platform that could soon make local delivery of biologic agents and small molecules safer and more effective, joint ventured with RBCC’s biotech subsidiary very recently. As noted in today’s press release, the global market for drug delivery technologies is driven by biologics and medications that can’t be administered effectively through traditional means. It is believed by some experts that the worldwide…
